A net-new flow that opened Noom Med to a segment it could never serve, turning people it used to turn away into a new audience.
The results moment, a screen I collaborated on rather than led: a personalized read keyed to the user's assessment, where someone who falls outside eligibility still feels seen.
Noom Med served people who were medically eligible for GLP-1 treatment. A large group wanted proactive health support but fell outside eligibility, so the business could not serve them.
Build a proactive-health path that serves this segment responsibly, assessing goals and signals and routing each person to the right program, without loosening a single clinical guardrail.
The assessment: start with easy, motivating questions, then layer in the clinical signals that make the recommendation real.
The forking logic, and there is a lot of it. Every path the flow routes a person down, by eligibility, goals, and clinical signals, with the guardrails that keep it responsible.
Editorial screens that do the convincing: this audience is not sick, so the flow sells proactive health, not treatment.
Roughly 4,000 signups in the first month, about 10% of all Med signups, from a segment the product previously could not serve. This is an access story, not a conversion-rate story: a routing experiment underperformed and was rolled back. The enduring win is the new audience.
Growth is not only optimization. Sometimes it is opening a door that was closed.